Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transcriptomic and network analysis reveal methionine sulfoxide reductases dependent regulation of flagellar motility in Salmonella Typhimurium.

Microbial pathogenesis·2026

Same author

Metabolic plasticity in pancreatic ductal adenocarcinoma progression and response to treatment.

Molecular cancer·2026

Same author

A 3.55-µm Ultrathin, Skin-Like Mechanoresponsive, Compliant, and Seamless Ionic Conductive Electrode for Epidermal Electrophysiological Signal Acquisition and Human-Machine Interaction.

Exploration (Beijing, China)·2025

Same author

PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy.

Autophagy·2025

Same author

Reply to: "The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates".

Communications medicine·2025

Same author

Estrogen-induced FXR1 promotes endocrine resistance and bone metastasis in breast cancer via BCL2 and GPX4.

Frontiers in cell and developmental biology·2025

Search research articles

Related Experiment Video

Updated: Sep 16, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Current Bioinformatics Tools in Precision Oncology.

Tesfaye Wolde¹, Vipul Bhardwaj², Vijay Pandey^1,2

¹Institute of Biopharmaceutical and Health Engineering Tsinghua Shenzhen International Graduate School Tsinghua University Shenzhen China.

|July 10, 2025

Summary

This summary is machine-generated.

Advanced bioinformatics tools are revolutionizing precision oncology by enabling the discovery of crucial molecular targets and cancer biomarkers from complex multiomics data. These computational methods enhance diagnostic accuracy and therapeutic efficacy for personalized cancer treatment.

Keywords:

bioinformatics biomarkers multiomic oncotherapeutics precision oncology

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Related Experiment Videos

Last Updated: Sep 16, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Area of Science:

Bioinformatics
Computational Biology
Genomics
Oncology

Background:

High-throughput sequencing and multiomics technologies generate complex datasets for precision oncology.
Extracting meaningful insights from these datasets requires robust computational methods.
Clinical application of multiomics data presents significant challenges.

Purpose of the Study:

To review advanced bioinformatics tools used in multiomics for cancer biomarker discovery.
To highlight the role of these tools in advancing precision oncology.
To discuss challenges and future directions in multiomics data integration.

Main Methods:

Exploration of cloud-based platforms (e.g., Galaxy, DNAnexus) for data processing.
Utilization of single-cell analysis software (e.g., Seurat) for identifying cellular subpopulations.
Integration of artificial intelligence (AI) and machine learning (ML) for predictive modeling.
Application of spatial omics technologies to analyze tumor microenvironments.

Main Results:

Bioinformatics tools streamline multiomics data processing and analysis.
AI/ML approaches enhance predictive modeling and diagnostic accuracy.
Spatial omics correlates molecular signatures with treatment strategies.
Collaborative initiatives (e.g., The Cancer Genome Atlas, cBioPortal) accelerate progress through data sharing and standardization.

Conclusions:

Bioinformatics integration is establishing a new standard in precision oncology, improving therapy efficacy.
Advancing multiomics integration and computational capabilities is crucial for biomarker discovery.
Future efforts should focus on merging multiomics with innovative computational methods for precision medicine.